Estimating optimal dose of twice-weekly gemcitabine for concurrent chemoradiotherapy in unresectable pancreatic carcinoma: mature results of GEMRT-01 Phase I trial.
about
New challenges in perioperative management of pancreatic cancerReversing the intractable nature of pancreatic cancer by selectively targeting ALDH-high, therapy-resistant cancer cellsPancreatic adenocarcinomaPhase I study evaluating the treatment of patients with locally advanced pancreatic cancer with carbon ion radiotherapy: the PHOENIX-01 trial.Pancreatic cancer: chemotherapy and radiotherapy.Radiation promotes epithelial-to-mesenchymal transition and invasion of pancreatic cancer cell by activating carcinoma-associated fibroblasts.Treatment options for advanced pancreatic cancer: a review.Advanced-stage pancreatic cancer: therapy options.Management options in locally advanced pancreatic cancer.Intensity modulated radiotherapy as neoadjuvant chemoradiation for the treatment of patients with locally advanced pancreatic cancer. Outcome analysis and comparison with a 3D-treated patient cohort.
P2860
Q28082422-7F15BDC0-31E8-4E3D-B0CC-9DAB4B080E38Q28534611-7E0450F0-44DA-4289-977C-5F38930EE154Q34140498-AD69F6E4-D20E-48E3-9024-0DB2CC0408F7Q34986932-0BBB4DA8-0A59-4F58-B8AA-3C8D70FF2A0EQ35913523-E127743D-12C8-4859-BE84-03D917F86324Q37382515-3D34813A-895F-4A65-895C-613B3A0A3B54Q38062020-C7F26C5A-7ED8-41A8-BFEE-25AC3043C14DQ38102914-1056C825-281F-4237-ACA3-9962ED9E3BF9Q38205127-1175C161-BB4F-493E-A280-B6A89B00D846Q39376002-8A6540A8-7039-49D9-A84D-991298C56E3C
P2860
Estimating optimal dose of twice-weekly gemcitabine for concurrent chemoradiotherapy in unresectable pancreatic carcinoma: mature results of GEMRT-01 Phase I trial.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Estimating optimal dose of twi ...... lts of GEMRT-01 Phase I trial.
@ast
Estimating optimal dose of twi ...... lts of GEMRT-01 Phase I trial.
@en
type
label
Estimating optimal dose of twi ...... lts of GEMRT-01 Phase I trial.
@ast
Estimating optimal dose of twi ...... lts of GEMRT-01 Phase I trial.
@en
prefLabel
Estimating optimal dose of twi ...... lts of GEMRT-01 Phase I trial.
@ast
Estimating optimal dose of twi ...... lts of GEMRT-01 Phase I trial.
@en
P2093
P1476
Estimating optimal dose of twi ...... lts of GEMRT-01 Phase I trial.
@en
P2093
Françoise Mornex
Nadine Bossard
Nicolas Girard
Virginie Wautot
P304
P356
10.1016/J.IJROBP.2009.06.053
P407
P577
2010-01-07T00:00:00Z